Biolase Inc

NASDAQ:BIOL   3:59:46 PM EDT
0.29
0.00 (-0.99%)
Earnings Announcements

BIOLASE Reports Q3 Rev Of $6.5 Mln

Published: 11/12/2020 21:49 GMT
BIOLASE Inc (BIOL) - Biolase Reports Strong Sequential Revenue Growth in Third Quarter 2020.
Q3 Revenue $6.5 Million Versus Refinitiv Ibes Estimate of $6.5 Million.
Qtrly Loss per Share $0.21.
Revenue is expected to be $7.43 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $6.96 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.